First-line Therapy With Nivolumab Plus Ipilimumab in Combination With Chemotherapy for Metatastatic NSCLC (NICReWo Trial)

Clinical trial NCT07190677 · RECRUITING

Trial details

NCT number: NCT07190677
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Status: RECRUITING
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Metastatic

Start date: 2025-01-17
Primary completion: 2025-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.